Matches in Wikidata for { <http://www.wikidata.org/entity/Q93200849> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q93200849 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93200849 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93200849 description "scientific article published on 01 November 2018" @default.
- Q93200849 description "wetenschappelijk artikel" @default.
- Q93200849 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93200849 name "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 name "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 type Item @default.
- Q93200849 label "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 label "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 prefLabel "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 prefLabel "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 P1433 Q93200849-EC8DCB51-5619-4AAC-960A-780879925A77 @default.
- Q93200849 P1476 Q93200849-38311CBE-FAA2-4989-9C53-097CAD49C4E5 @default.
- Q93200849 P2093 Q93200849-05B9196A-8727-42FF-80F9-CE33BF5AA07A @default.
- Q93200849 P2093 Q93200849-64CB17EE-C9E9-4015-8985-5EC4F701222C @default.
- Q93200849 P2093 Q93200849-DCDDF8CF-0B0E-421F-9908-D1F5F30EB98B @default.
- Q93200849 P2093 Q93200849-EA0C6C97-2809-4713-9DEE-F2C41FAA9520 @default.
- Q93200849 P304 Q93200849-076A87FD-2397-4EE6-89E4-F858A7872EAE @default.
- Q93200849 P31 Q93200849-AAB0D838-2A3E-45B8-BDFD-ADE839C15349 @default.
- Q93200849 P433 Q93200849-13F42328-A476-4BD0-8E5A-CCA8ABFDF5A4 @default.
- Q93200849 P478 Q93200849-83707CEB-EDC9-424C-8993-AD76B4DC01FE @default.
- Q93200849 P577 Q93200849-54CC7438-8B19-4F55-B20D-AF755CA7E8C5 @default.
- Q93200849 P698 Q93200849-F24369EE-AB8F-449A-803E-AE696408DA5D @default.
- Q93200849 P921 Q93200849-B3ED4AB2-C5A0-4946-B151-D555AEBFDF43 @default.
- Q93200849 P921 Q93200849-CBE3D5B4-2C81-4B53-893F-9741CC0FAAE7 @default.
- Q93200849 P698 30449854 @default.
- Q93200849 P1433 Q27709096 @default.
- Q93200849 P1476 "[A Case in Which Toxic Epidermal Necrosis Developed during Treatment with the Immune Checkpoint Inhibitor Pembrolizumab for Recurrent Patients Following Lung Cancer Surgery]" @default.
- Q93200849 P2093 "Norihiko Hata" @default.
- Q93200849 P2093 "Syogo Takahashi" @default.
- Q93200849 P2093 "Tomohiro Tsujita" @default.
- Q93200849 P2093 "Toshimichi Oinuma" @default.
- Q93200849 P304 "1641-1644" @default.
- Q93200849 P31 Q13442814 @default.
- Q93200849 P433 "11" @default.
- Q93200849 P478 "45" @default.
- Q93200849 P577 "2018-11-01T00:00:00Z" @default.
- Q93200849 P698 "30449854" @default.
- Q93200849 P921 Q13896859 @default.
- Q93200849 P921 Q6704283 @default.